Key Influencer in the Digital Diagnostics Market 2025: Rising Chronic Illness Cases Driving Growth In The Market Driver

What Is the Forecasted Market Size and Growth Rate for the Digital Diagnostics Market?
The market size of digital diagnostics has seen incredible growth recently. Predictions indicate a growth from $1.76 billion in 2024 to $2.16 billion in 2025, featuring a compound annual growth rate (CAGR) of 22.7%. The significant growth during the historical period is the result of increased investment and support, heightened awareness and education, more financing directed towards research and development, a greater focus on ESG factors, and a rise in approaches centered around the patients.

The future looks promising for the digital diagnostics market, with projections indicating an impressive upswing in the coming years. The market hopes to scale up to a whopping $4.86 billion by the year 2029, boasting a compound annual growth rate (CAGR) of 22.4%. Numerous factors drive this expected surges, including worldwide health directives, the rising commonality of healthcare, a societal shift towards digital platforms, backing from medical institutions, and an increase in diagnostic scopes. The forecast period will likely see an increased emphasis on point-of-care testing, burgeoning telemedicine solutions, advances in software technology, the expansion of digital pathology solutions, and the use of blockchain for information protection.

What Factors Are Propelling the Expansion of the Digital Diagnostics Market?
Growing instances of chronic diseases are anticipated to fuel the expansion of the digital diagnostics market. Factors such as aging demographics, accelerating rates of obesity, inactive lifestyle habits, environmental factors, and enhanced detection and understanding of these diseases are causing an upsurge in chronic illnesses. Digital diagnostics plays a pivotal role in managing chronic ailments through continual monitoring, timely detection of complications and tailored treatment adjustments, thereby enhancing long-term disease control and patient prognosis. For instance, the World Health Organization, a Switzerland-based international body, reported somewhere around 20 million fresh cancer cases and approximately 9.7 million cancer-related fatalities in 2022, in February 2024. Lung cancer, with 2.5 million new cases, accounting for 12.4% of total new cases, was found to be the prevalent type. The next most rampant were female breast cancer with 2.3 million cases (11.6%), colorectal cancer with 1.9 million cases (9.6%), prostate cancer with 1.5 million cases (7.3%), and stomach cancer with 970,000 cases (4.9%). The most significant upsurge in incidence, in terms of total burden, is projected in countries with a high Human Development Index (HDI), with an additional 4.8 million new cases expected for 2050, in contrast with 2022. Consequently, the rise in chronic illness cases is fuelling the expansion of the digital diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20748&type=smp

Which Businesses Are at the Forefront of Digital Diagnostics Market Development?
Major companies operating in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., GRAIL Inc.

What Are the Major Trends Shaping the Digital Diagnostics Market?
Key players in the digital diagnostics field are emphasizing on the creation of advanced products like digital cytology systems. This is to improve diagnostic accuracy, optimize workflows, and permit remote analysis via sophisticated imaging and AI-enhanced tools. The digital cytology system is an innovative diagnostic platform that employs imaging technology and artificial intelligence to analyse and decipher cytological samples for precise and efficient medical diagnoses. In February 2024, Hologic Inc., a medical technology firm based in the US, declared the FDA approval for its Genius Digital Diagnostics System incorporated with the Genius Cervical AI algorithm. This system is recognized as the first and only FDA-endorsed digital cytology platform that amalgamates deep-learning-based AI with high-level volumetric imaging to detect pre-cancerous lesions and cervical cancer cells. Unlike the conventional methods where cervical cells are collected during a Pap test and scrutinized manually under a microscope, this system digitalizes the glass slides and utilizes AI to emphasize critical cells for cytologists and pathologists to examine.

How Is the Digital Diagnostics Market Segmented?
The digital diagnostics market covered in this report is segmented -

1) By Product: Hardware, Software, Services
2) By Application: Cardiology, Gynecology, Infectious Diseases, Oncology, Diabetes, Other Applications
3) By End-Users: Hospitals And Clinics, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:
1 By Hardware: Diagnostic Devices, Wearable Devices, Sensors And Monitoring Equipment
2) By Software: Diagnostic Software, Data Analytics Software, Artificial Intelligence (AI) And Machine Learning Software, Cloud-Based Platforms
3) By Services: Diagnostic Testing Services, Telemedicine And Remote Monitoring Services, Data Management And Analytics Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/digital-diagnostics-global-market-report

Where Is the Digital Diagnostics Market Growth Most Prominent?
North America was the largest region in the digital diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Digital Diagnostics Global Market Report?

- Market Size Analysis: Analyze the digital diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the digital diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall digital diagnostics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the digital diagnostics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20748

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.